Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

122 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Chemotherapy de-escalation using an 18F-FDG-PET-based pathological response-adapted strategy in patients with HER2-positive early breast cancer (PHERGain): a multicentre, randomised, open-label, non-comparative, phase 2 trial.
Pérez-García JM, Gebhart G, Ruiz Borrego M, Stradella A, Bermejo B, Schmid P, Marmé F, Escrivá-de-Romani S, Calvo L, Ribelles N, Martinez N, Albacar C, Prat A, Dalenc F, Kerrou K, Colleoni M, Afonso N, Di Cosimo S, Sampayo-Cordero M, Malfettone A, Cortés J, Llombart-Cussac A; PHERGain steering committee and trial investigators. Pérez-García JM, et al. Among authors: kerrou k. Lancet Oncol. 2021 Jun;22(6):858-871. doi: 10.1016/S1470-2045(21)00122-4. Epub 2021 May 18. Lancet Oncol. 2021. PMID: 34019819 Clinical Trial.
Detection of hepatocellular carcinoma with PET/CT: a prospective comparison of 18F-fluorocholine and 18F-FDG in patients with cirrhosis or chronic liver disease.
Talbot JN, Fartoux L, Balogova S, Nataf V, Kerrou K, Gutman F, Huchet V, Ancel D, Grange JD, Rosmorduc O. Talbot JN, et al. Among authors: kerrou k. J Nucl Med. 2010 Nov;51(11):1699-706. doi: 10.2967/jnumed.110.075507. Epub 2010 Oct 18. J Nucl Med. 2010. PMID: 20956466 Free article. Clinical Trial.
Impact of FDG PET/CT in the staging and the follow-up of anal carcinoma.
Vercellino L, Montravers F, de Parades V, Huchet V, Kerrou K, Bauer P, Touboul E, Talbot JN. Vercellino L, et al. Among authors: kerrou k. Int J Colorectal Dis. 2011 Feb;26(2):201-10. doi: 10.1007/s00384-010-1080-9. Int J Colorectal Dis. 2011. PMID: 21061012
[Positron emission tomography (PET) in gastrointestinal cancer].
Montravers F, Grahek D, Kerrou K, Gutman F, Talbot JN. Montravers F, et al. Among authors: kerrou k. Gastroenterol Clin Biol. 2006 May;30(5):737-41. doi: 10.1016/s0399-8320(06)73306-1. Gastroenterol Clin Biol. 2006. PMID: 16801895 Free article. Review. French. No abstract available.
[FDG PET and its impact on patient's management in oncology].
Talbot JN, Montravers F, Grahek D, Kerrou K, Gutman F, Cailleux N. Talbot JN, et al. Among authors: kerrou k. Presse Med. 2006 Sep;35(9 Pt 2):1339-46. doi: 10.1016/s0755-4982(06)74817-5. Presse Med. 2006. PMID: 16969330 Review. French.
[PET in head and neck cancers].
Talbot JN, Périé S, Kerrou K, Montravers F, Balogova S, Grahek D, Gutman F, Saint Guily JL. Talbot JN, et al. Among authors: kerrou k. Presse Med. 2006 Sep;35(9 Pt 2):1355-69. doi: 10.1016/s0755-4982(06)74819-9. Presse Med. 2006. PMID: 16969332 Review. French.
122 results